创伤后应激障碍中促肾上腺皮质激素对地塞米松的反应。

The ACTH response to dexamethasone in PTSD.

作者信息

Yehuda Rachel, Golier Julia A, Halligan Sarah L, Meaney Michael, Bierer Linda M

机构信息

Traumatic Stress Studies Program, Department of Psychiatry, Mount Sinai School of Medicine, and Bronx Veterans Affairs Medical Center, New York, USA.

出版信息

Am J Psychiatry. 2004 Aug;161(8):1397-403. doi: 10.1176/appi.ajp.161.8.1397.

Abstract

OBJECTIVE

Enhanced negative feedback and reduced adrenal output are two different models that have been put forth to explain the paradoxical observations of increased release of corticotropin-releasing factor in the face of low cortisol levels in posttraumatic stress disorder (PTSD). To discriminate between these models, the authors measured levels of adrenocorticopic hormone (ACTH) and cortisol at baseline and in response to dexamethasone in medically healthy subjects with and without PTSD. Under conditions of enhanced negative feedback inhibition, ACTH levels would not be altered relative to cortisol levels, but the ACTH response to dexamethasone would be augmented, in concert with the enhanced cortisol response to dexamethasone. In contrast, under conditions of reduced adrenal output, ACTH levels would be expected to be higher at baseline relative to cortisol levels, but the ACTH response to dexamethasone would be unchanged in PTSD relative to healthy comparison subjects.

METHOD

The ACTH and cortisol responses to 0.50 mg of dexamethasone were assessed in 19 subjects (15 men and four women) with PTSD and 19 subjects (14 men and five women) without psychiatric disorder.

RESULTS

The ACTH-to-cortisol ratio did not differ between groups before or after dexamethasone, but the subjects with PTSD showed greater suppression of ACTH (as well as cortisol) in response to dexamethasone.

CONCLUSIONS

The data support the hypothesis of enhanced cortisol negative feedback inhibition of ACTH secretion at the level of the pituitary in PTSD. Pituitary glucocorticoid receptor binding, rather than low adrenal output, is implicated as a likely mechanism for this effect.

摘要

目的

增强负反馈和肾上腺输出减少是两种不同的模型,已被提出用于解释创伤后应激障碍(PTSD)中面对低皮质醇水平时促肾上腺皮质激素释放因子释放增加这一矛盾现象。为区分这些模型,作者测量了患有和未患有PTSD的医学健康受试者在基线时以及对地塞米松反应时的促肾上腺皮质激素(ACTH)和皮质醇水平。在增强负反馈抑制的情况下,ACTH水平相对于皮质醇水平不会改变,但ACTH对地塞米松的反应会增强,这与皮质醇对地塞米松的反应增强相一致。相反,在肾上腺输出减少的情况下,相对于皮质醇水平,预计PTSD患者的ACTH基线水平会更高,但PTSD患者对地塞米松的ACTH反应相对于健康对照受试者将保持不变。

方法

评估了19名患有PTSD的受试者(15名男性和4名女性)和19名无精神疾病的受试者(14名男性和5名女性)对0.50 mg地塞米松的ACTH和皮质醇反应。

结果

地塞米松给药前后,两组的ACTH与皮质醇比值无差异,但患有PTSD的受试者对地塞米松的反应显示出ACTH(以及皮质醇)的更大抑制。

结论

数据支持PTSD患者垂体水平上皮质醇对ACTH分泌的负反馈抑制增强的假说。垂体糖皮质激素受体结合而非肾上腺输出减少被认为是这种效应的可能机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索